Skip to product information
Ipamorelin+CJC-1295 no DAC
  • Ipamorelin+CJC-1295 no DAC
  • Ipamorelin+CJC-1295 no DAC
Ipamorelin+CJC-1295 no DAC
€55,00
Amount

Overview
This research-grade blend combines Ipamorelin, a selective growth hormone secretagogue, with CJC-1295 (without DAC), a synthetic GHRH analog with standard half-life. The combination is used in laboratory research to investigate synergistic effects on growth hormone release, endocrine signaling, and metabolic pathways. This product is intended strictly for scientific research and is not for human consumption, medical use, or diagnostic purposes.

Research Focus
In preclinical and laboratory studies, this peptide blend is commonly studied for:

  • Enhanced growth hormone release – combining Ipamorelin’s selective receptor activation with CJC-1295’s GHRH analog activity.

  • Endocrine and pituitary signaling – analyzing interactions in hypothalamic–pituitary pathways.

  • Metabolic regulation – investigating effects on energy balance and cellular metabolism.

  • Body composition and tissue research – exploring pathways affecting lean mass and fat distribution in experimental models.

Key Features

  • Research-grade peptide blend of Ipamorelin + CJC-1295 (No DAC)

  • Lyophilized powder for stability in laboratory settings

  • High-purity formulation suitable for preclinical research

  • Manufactured to stringent quality standards

Specifications

  • Components: Ipamorelin + CJC-1295 (No DAC)

  • Form: Lyophilized powder

  • Purity: ≥98% (HPLC)

  • Storage: Store at –20°C; stable under recommended conditions

  • Intended Use: Research use only. Not for human consumption, medical, or veterinary use.

Disclaimer
This material is supplied for laboratory research purposes only. It is not a drug, food, or cosmetic. The buyer assumes all responsibility for safe handling and lawful use.

You may also like